Alison Munro

Search results

• 2024

  P26.01.B A PHARMACOLOGICAL SURVEY ACROSS GLIOMA STEM CELL PHENOTYPES REVEAL NOVEL GLIOBLASTOMA DRUG-TARGETS, DRUG REPURPOSING OPPORTUNITIES AND FUTURE DRUG COMBINATION STRATEGIES

  Elliott, R., Furqan, M., Nagle, P., Munro, A., Drake, C., Dawson, J. C., Brunton, V., Frame, M. & Carragher, N. O., 17 Oct 2024, In: Neuro-Oncology. 26, Supplement_5, p. v132-v132

  Research output: Contribution to journal › Meeting abstract › peer-review
• 2021

  P-OGC32 Copper-dependent cell death is a cancer specific vulnerability in oesophageal adenocarcinoma and provides the opportunity for future biomarker-stratified clinical trials

  Hughes, R. E., Elliott, R., Munro, A., Hupp, T., Carragher, N. O. & O'neill, J. R., 15 Dec 2021, In: British Journal of Surgery. 108, Supplement_9

  Research output: Contribution to journal › Meeting abstract
• 2010

  Duplication of chromosome 17 CEP predicts for anthracycline benefit: evidence from an international meta-analysis of 4 adjuvant breast cancer trials for the HER2/TOP2A meta-analysis study group

  Bartlett, J. M. S., Munro, A., O'Malley, F. P., Earl, H., Poole, C. J., Cardoso, F., Twelves, C. J., Pritchard, K. I., Rea, D. W. & Di Leo, A., Mar 2010, In: European Journal of Cancer - Supplement. 8, 3, p. 121-121 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• 2009

  BUBR1 and MAD2: Novel Markers for Predicting Benefit from Adjuvant Anthracyclines?

  Munro, A. F., Cameron, D. A., Thomas, J., Twelves, C. J. & Bartlett, J. M. S., 15 Dec 2009, In: Cancer Research. 69, 24, p. 632S-633S 2 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Duplication of Chromosome 17 CEP Predicts for Anthracycline Benefit: A Meta-Analysis of 4 Trials

  HER2 TOP2A Meta Anal Grp, Bartlett, J. M. S., Munro, A., Desmedt, C., Dunn, J. A., Larsimont, D., O'Malley, F. P., Cameron, D. A., Earl, H., Poole, C. J., Shepherd, L., Cardoso, F., Caldas, C., Twelves, C. J., Pritchard, K., Rea, D. W. & diLeo, A., 15 Dec 2009, In: Cancer Research. 69, 24, p. 716S-716S 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Chromosome 17 polysomy: a unifying hypothesis underlying benefit from adjuvant anthracyclines?

  HER2 TIIa Metaanal Grp, Bartlett, J. M. S., Desmedt, C., Munro, A., O'Malley, F. P., Larsimont, D., di Leo, A., Cameron, D. A., Isola, J., Shepherd, L., Twelves, C. J. & Pritchard, K., 15 Jan 2009, In: Cancer Research. 69, 2, p. 364S-364S 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• Chromosome 17 polysomy (Ch17) as a predictor of anthracycline response: emerging evidence from the UK NEA Tadjuvant breast cancer trial

  Bartlett, J. M. S., Munro, A., Dunn, J. A., Hiller, L., Jordan, S., Twelves, C. J., Cameron, D. A., Thomas, J., Campbell, F., Rea, D. W., Provenzano, E., Pharoah, P., Caldas, C., Earl, H. & Poole, C. J., 15 Jan 2009, In: Cancer Research. 69, 2, p. 74S-74S 1 p.

  Research output: Contribution to journal › Meeting abstract › peer-review

• The use of proximity ligation assay to identify HER2:HER3 heterodimers in early breast cancers

  Spears, M., Munro, A. F., Taylor, K. J., Mallon, E. A. & Bartlett, J. M. S., 15 Jan 2009, In: Cancer Research. 69, 2, p. 176S-177S 2 p.

  Research output: Contribution to journal › Meeting abstract › peer-review